Neuro-ophthalmology of diabetes

Current Opinion in Ophthalmology

Volumn 10, Issue 6, 1999, Pages 376-381

  Moster, Mark L ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CRANIAL NEUROPATHY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EYE MOVEMENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRIS DISEASE; ISCHEMIC OPTIC NEUROPATHY; MUCORMYCOSIS; NEUROOPHTHALMOLOGY; OPTIC NERVE HYPOPLASIA; PRIORITY JOURNAL; PUPIL DISEASE; STROKE; SYNDROME; VISION;

BLINDNESS; DELIVERY OF HEALTH CARE; DIABETES COMPLICATIONS; DIABETES MELLITUS; EYE ABNORMALITIES; HUMANS; MACULAR EDEMA, CYSTOID; OCULAR MOTILITY DISORDERS; OPTIC NEUROPATHY, ISCHEMIC; VISUAL ACUITY;

EID: 0032749040     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199912000-00003     Document Type: Article

References (45)

1. 1 Sadun AA: Guest Editorial: Neuro-ophthalmic manifestations of diabetes. Ophthalmology 1999, 106:1047-1048. This editorial gives a comprehensive but succinct review of the neuroophthalmologic manifestations of DM.
2. 2 Salomon O, Huna-Baron R, Kurtz S, Steinberg DM, Moisseiev J, Rosenberg N, et al.: Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1999, 106: 739-742.
3. 3 Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995, 273:625-632.
4. 4 Tomsak RL, Zakov ZN: Nonarteritic anterior ischemic optic neuropathy with macular edema: visual improvement and fluorescein angiographic characteristics. J Neuroophthalmol 1998, 18:166-168. This review found that among patients with NAION, those with co-existing macular edema have better visual prognosis than do those without macular edema.
5. 5 Alexandrakis G, Lam BL: Bilateral posterior ischemic optic neuropathy after spinal surgery. Am J Ophthalmol 1999, 127:354-355.
6. 6 Fivgas GD, Newman NJ: Anterior ischemic optic neuropathy following the use of a nasal decongestant. Am J Ophthalmol 1999, 172:104-106.
7. 7 Wijaya J, Salu P, Leblanc A, Bervoets S: Acute unilateral visual loss due to a single intranasal methamphetamine abuse. Bull Soc Belge Ophtalmol 1999, 271:19-25.
8. 8 Wang MY, Sadun F, Levin LB, LaBree L, Feldon SE: Occurrence of familial nonarteritic anterior ischemic optic neuropathy in a case series. J Neuroophthalmol 1999, 19:144-147.
9. 9 Lessel S: Nonarteritic anterior ischemic optic neuropathy: enigma variations [editorial]. Arch Ophthalmol 1999, 11 7:386-388. This editorial points out that we really do not know the pathogenesis of NAION. Despite its frequent association with DM, NAION is often seen in patients without obvious vascular risk factors.
10. 10 Jacobson DM: Pupil involvement in patients with diabetes-associated oculomotor nerve palsy. Arch Ophthalmol 1998, 116:723-727. This study documents that 38% of patients with diabetic third-nerve palsies have anisocoria. However, anisocoria was greater than 2 mm in only one patient in this study.
11. 11 Trobe JD: Managing oculomotor nerve palsy [editorial]. Arch Ophthalmol 1998, 116:798. This editorial, which accompanied the paper by Jacobson [10•], emphasizes that when anisocoria is greater than 2 mm in a patient with isolated third-nerve palsy, catheter angiography should be done.
12. 12 Thomke F, Ringel K, Schindler H, Hopf HC: Pupil-sparing oculomotor palsy as the only clinical sign of an internal carotid artery occlusion. Eur J Neural 1999, 6:378.
13. 13 Balcer LJ, Galetta SL, Yousem DM, Golden MA, Asbury AK: Pupil-involving third-nerve palsy and carotid stenosis: rapid recovery endarterectomy. Ann Neural 1997, 41:273-276.
14. 14 Keane JR, Ahmadi J: Most diabetic third nerve palsies are peripheral. Neurology 1998, 51:1510.
15. 15 Eggenberger E: Eight-and-a-half syndrome: one-and-a-half syndrome plus cranial nerve VII palsy. J Neuroophthalmol 1998, 18:114-116.
16. 16 Mudgil AV, Repka MX: Ophthalmologic outcome after third cranial nerve palsy or paresis in childhood. J AAPOS 1999, 3:2-8.
17. 17 Miller RW, Lee AG, Schiffman JS, Prager TC, Garza R, Jenkins PF, et al.: A practice pathway for the initial diagnostic evaluation of isolated sixth cranial nerve palsies. Med Decis Making 1999, 19:42-48.
18. 18 Apfel SC, Kessler JA, Adornato BT, Litchy WJ, Sanders C, Rask CA: Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology 1998, 51:695-702.
19. 19 Smith SA, Smith SE: Evidence for a neuropathic aetiology in the small pupil of diabetes mellitus. Br J Ophthalmol 1983, 67:89-93.
20. 20 Sigsbee B, Torkelson R, Kadis G, Wright JW, Reeves AG: Parasympathetic denervation of the iris in diabetes mellitus. J Neurol Neurosurg Psychiatry 1974, 37:1031-1035.
21. 21 Zaczek A, Zotterstrom C: The effect of phenylephrine and pilocarpine on pupil size and aqueous flare intensity in patients with diabetes mellitus. Acta Ophthalmol Scand 1998, 76:41 3-416.
22. 22 Jacobson DM, Vierkant RA: Comparison of cholinergic supersensitivity in third nerve palsy and Adie's syndrome. J Neuroophthalmol 1998, 18:171-175.
23. 23 Smith SA, Smith SE: Bilateral Horner's syndrome: detection and occurrence. J Neurol Neurosurg Psychiatry 1999, 66:48-51.
24. 24 Weetman AP, Wiersing WM: Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey. Clin Endocrinol (Oxf) 1998, 49:21-28.
25. 25 Polak BCP, Winjgaarde R: Radiation retinopathy in patients with both diabetes mellitus and ophthalmic Graves' disease. Orbit 1995, 14:71-74.
26. 26 Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R: Clinical criteria for the assessment of disease activity in Graves ophthalmopathy: a novel approach. Br J Ophthalmol 1989, 73:639-644.
27. 27 Hansen D, Bennedback FN, Hansen LK, Hoier-Madsen M, Jacobsen BB, Hegedus L: Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus. Eur J Endocrinol 1999, 140:512-518.
28. 28 Rocha G, Garza G, Font RL: Orbital pathology associated with diabetes mellitus. Int Ophthalmol Clin 1998, 38:169-179.
29. 29 Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, Hansen MD: Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in acute stroke treatment (TOAST) investigators. Neurology 1999, 52:280-284.
30. 30 Jaillard A, Cornu C, Durioux A, Moulin T, Boutitie F, Lees KR, Hommel M: Hemorrhage transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke 1999, 30:1326-1332.
31. 31 Pocecco M, Ronfani L: Transient focal neurologic deficits associated with hypoglycaemia in children with insulin-dependent diabetes mellitus. Acta Paediatr 1998, 87:542-544. This study reviews 54 episodes of transient neurologic deficits resulting from hypoglycemia in children. Eight episodes were preceded by a seizure, and episodes often did not resolve promptly with administration of sugar. However, because prognosis is good, detailed investigations are not required.
32. 32 Ewing FM, Deary IJ, McCrimmon RJ, Strachan MW, Frier BM: Effect of acute hypoglycemia on visual information processing in adults with type 1 diabetes mellitus. Physiol Behav 1998, 64:653-660.
33. 33 Russell-Eggitt IM, Clayton PT, Coffey R, Kriss A, Taylor DS, Taylor JF: Alstrom syndrome. Report of 22 cases and literature review. Ophthalmology 1998, 105:1274-1280.
34. 34 Swift RG, Polymeropoulos MH, Torres R, Swift M: Predisposition of Wolfram syndrome heterozygotes to psychiatric illness. Mol Psychiatry 1998, 3:86-91.
35. 35 Ohata T, Koizumi A, Kayo T, Shoji Y, Watanabe A, Monoh K, et al.: Evidence of an increased risk of hearing loss in heterozygous carriers in a Wolfram syndrome family. Hum Genet 1998, 103:470-474.
36. 36 Takiyama Y, Sakoe K, Namekawa M, Soutome M, Esumi E, Ogawa T, et al.: A Japanese family with spinocerebellar ataxia type 6 which includes three individuals homozygous for an expanded CAG repeat in the SCA6/CACNL1A4 gene. J Neurol Sci 1998, 153:141-147.
37. 37 Ruza Paz-Curbera E, Fernandez Benitez M: Melkersson-Rosenthal syndrome in a diabetic boy. Allergol Immunopathol (Madr) 1998, 26:291-293.
38. 38 Okada Y, Kawamoto S, Yoshida S: High serum levels of somatomedin-C and diabetes mellitus caused by obstructive hydrocephalus: case report. Neurosurgery 1998, 42:1172-1175.
39. 39 Bazargan M, Baker RS, Bazargan S: Correlates of recency of eye examination among elderly African-Americans. Ophthalmic Epidemiol 1998, 5:91-100.
40. 40 Gaudette RE, Lucas SJ, Hogan AS: Managed care and eye services to diabetic patients: a study of participant behavior. J Am Optom Assoc 1998, 69:531-537.
41. 41 Cox DJ, Kiernan BD, Schroeder DB, Cowley M: Psychosocial sequelae of visual loss in diabetes. Diabetes Educator 1998, 24:481-484.
42. 42 Ino-ue M, Azumi A, Kajiura-Tsukahara Y, Yamamoto M: Ocular ischemic syndrome in diabetic patients. Jpn J Ophthalmol 1999, 43:31-35. This study shows that among patients with ocular ischemic syndrome, those with iris neovascularization have worse visual outcome than do those without iris neovascularization.
43. 43 Hayreh SS: Retinal and optic nerve head ischemic disorders and atherosclerosis: role of serotonin. Progress in Retinal and Eye Research 1999, 18:191-221.
44. 44 Landau K, Bajka JD, Kirschschlager BM: Topless optic disks in children of mothers with type I diabetes mellitus. Am J Ophthalmol 1998, 125:605-611.
45. 45 Ricci B, Scullica MG, Ricci F, Santo A: Iris vascular changes in newborns of diabetic mothers. Ophthalmologica 1998, 212:175-177.